Cargando…

HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2

BACKGROUND: HIV proteins Nef and Vpu down-modulate various host factors to evade immune defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion-tethering BST2 is depleted by Vpu. Antibody-dependent cell-mediated cytotoxicity (ADCC) is increasingly recognized as a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Tram NQ, Lukhele, Sabelo, Hajjar, Fadi, Routy, Jean-Pierre, Cohen, Éric A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930549/
https://www.ncbi.nlm.nih.gov/pubmed/24498878
http://dx.doi.org/10.1186/1742-4690-11-15
_version_ 1782304543628853248
author Pham, Tram NQ
Lukhele, Sabelo
Hajjar, Fadi
Routy, Jean-Pierre
Cohen, Éric A
author_facet Pham, Tram NQ
Lukhele, Sabelo
Hajjar, Fadi
Routy, Jean-Pierre
Cohen, Éric A
author_sort Pham, Tram NQ
collection PubMed
description BACKGROUND: HIV proteins Nef and Vpu down-modulate various host factors to evade immune defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion-tethering BST2 is depleted by Vpu. Antibody-dependent cell-mediated cytotoxicity (ADCC) is increasingly recognized as a potentially powerful anti-HIV response. Given that epitopes which are specific for ADCC-competent anti-HIV antibodies are transitionally exposed upon CD4-mediated HIV entry, we investigated whether by depleting CD4 and BST2, HIV could negatively affect ADCC function. RESULTS: Using anti-envelope (Env) Abs A32 and 2G12 to trigger ADCC activity, we find that interactions between CD4 and Env within infected cells expose ADCC-targeted epitopes on cell-surface Env molecules, marking infected T cells for lysis by immune cells. We also provide evidence to show that by cross-linking nascent virions at the plasma membrane, hence increasing cell-surface Env density, BST2 further enhances the efficiency of this antiviral process. The heightened susceptibility of T cells infected with a virus lacking Nef and Vpu to ADCC was recapitulated when plasmas from HIV-infected patients were used as an alternative source of Abs. CONCLUSIONS: Our data unveil a mechanism by which HIV Nef and Vpu function synergistically to protect infected cells from ADCC and promote viral persistence. These findings also renew the potential practical relevance of ADCC function in vivo.
format Online
Article
Text
id pubmed-3930549
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39305492014-02-21 HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 Pham, Tram NQ Lukhele, Sabelo Hajjar, Fadi Routy, Jean-Pierre Cohen, Éric A Retrovirology Research BACKGROUND: HIV proteins Nef and Vpu down-modulate various host factors to evade immune defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion-tethering BST2 is depleted by Vpu. Antibody-dependent cell-mediated cytotoxicity (ADCC) is increasingly recognized as a potentially powerful anti-HIV response. Given that epitopes which are specific for ADCC-competent anti-HIV antibodies are transitionally exposed upon CD4-mediated HIV entry, we investigated whether by depleting CD4 and BST2, HIV could negatively affect ADCC function. RESULTS: Using anti-envelope (Env) Abs A32 and 2G12 to trigger ADCC activity, we find that interactions between CD4 and Env within infected cells expose ADCC-targeted epitopes on cell-surface Env molecules, marking infected T cells for lysis by immune cells. We also provide evidence to show that by cross-linking nascent virions at the plasma membrane, hence increasing cell-surface Env density, BST2 further enhances the efficiency of this antiviral process. The heightened susceptibility of T cells infected with a virus lacking Nef and Vpu to ADCC was recapitulated when plasmas from HIV-infected patients were used as an alternative source of Abs. CONCLUSIONS: Our data unveil a mechanism by which HIV Nef and Vpu function synergistically to protect infected cells from ADCC and promote viral persistence. These findings also renew the potential practical relevance of ADCC function in vivo. BioMed Central 2014-02-06 /pmc/articles/PMC3930549/ /pubmed/24498878 http://dx.doi.org/10.1186/1742-4690-11-15 Text en Copyright © 2014 Pham et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pham, Tram NQ
Lukhele, Sabelo
Hajjar, Fadi
Routy, Jean-Pierre
Cohen, Éric A
HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
title HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
title_full HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
title_fullStr HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
title_full_unstemmed HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
title_short HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
title_sort hiv nef and vpu protect hiv-infected cd4+ t cells from antibody-mediated cell lysis through down-modulation of cd4 and bst2
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930549/
https://www.ncbi.nlm.nih.gov/pubmed/24498878
http://dx.doi.org/10.1186/1742-4690-11-15
work_keys_str_mv AT phamtramnq hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2
AT lukhelesabelo hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2
AT hajjarfadi hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2
AT routyjeanpierre hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2
AT cohenerica hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2